Interleukin-1-beta New Formulation

Preferred Label : Interleukin-1-beta New Formulation;

NCIt synonyms : IL-1 beta New Formulation;

NCIt definition : An aqueous therapeutic analogue of the endogenous cytokine interleukin-1-beta (IL-1-beta). Produced mainly by monocytes, endogenous IL-1-beta plays a role in hematopoiesis, is a potent stimulator of T-cell activity, and may promote or inhibit tumor growth, depending on tumor type. (NCI04);

NSC code : 647860;

Détails

Origin ID

C29985;

UMLS CUI

C1512839;

Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
chemical_or_drug_affects_gene_product
- Interleukin-1 Receptor Type 2 [NCIt concept]
chemical_or_drug_has_mechanism_of_action
- Cytokine Receptor Activation [NCIt concept]
chemical_or_drug_has_physiologic_effect
- Hematopoiesis Induction [NCIt concept]
- Immunopotentiation [NCIt concept]
- Inhibition of Cell Proliferation [NCIt concept]
- Receptor Activation Process [NCIt concept]
- T-Cell Activation [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients